Ellie: GLP-1 Taper & Maintain logo

Ellie: GLP-1 Taper & Maintain

Launching now

Ellie is a GLP-1 maintenance app with a week-by-week plan for tapering, stretching doses, or staying off, so you can hold your results.

Ellie: GLP-1 Taper & Maintain - Product Image

Ellie is a health companion app designed for people who are coming off GLP-1 medications such as Ozempic, Wegovy, Zepbound, or Mounjaro. It provides a week-by-week plan for tapering your dose, stretching doses with your prescriber, or maintaining your results after your last injection. The app is built around the idea that the hardest part is already done, and the real challenge is keeping the weight off when the medication stops suppressing appetite.

Ellie turns published research and real-world clinic data into a practical structure. The app tracks your weight trends, gives you a personalized After Plan, and includes tools like Food Noise SOS for moments when cravings spike. It is an educational companion, not medical advice, and never recommends specific doses. Instead, it helps you hold the number you decided not to cross.

Key Features

  • The After Plan: A week-by-week timeline from your last dose or current taper, showing when water-weight jumps, when food noise peaks, and what to do in each phase so nothing surprises you.
  • Food Noise SOS: A ten-minute protocol for moments when thoughts about food get loud, with a chart that shows the noise fading over weeks.
  • The line you will not cross: Set your boundary once, and Ellie watches the 7-day trend, not a single weigh-in, to catch drift at 4 lbs instead of 20.
  • Protein and strength floor: Simple daily protein targets and 20-minute home strength sessions that protect muscle while you hold your weight, without cardio guilt.
  • Medication modeling: Ellie adapts to standard weekly doses, stretched intervals, stepped-down tapers, or life after your last dose, and never suggests a dose.
  • Bring-to-your-prescriber export: A one-page summary of your real regimen, trend, and plan, so conversations with your doctor start from data.

Who Should Use Ellie

  • People who are currently on a GLP-1 medication and want to taper or stretch their dose while holding their weight.
  • People who have stopped taking Ozempic, Wegovy, Zepbound, or Mounjaro and want a structured plan to avoid regain.
  • People who have already maintained for months and want a tool that catches small drift before it becomes a larger problem.
  • Healthcare-adjacent users who prefer evidence-based, cited educational tools to pair with their clinician's guidance.

Frequently Asked Questions

Do I have to be off my medication to use Ellie?

No. Ellie is for holding your number on the medication, on less of it, or off it entirely. The plan adapts to whatever you and your clinician decided, including stretching doses, tapering, rationing a final box, or being fully done.

Which medications does it cover?

Ellie covers Zepbound, Mounjaro, Wegovy, Ozempic, the oral versions, and compounded semaglutide or tirzepatide. It models the level of whatever you actually take.

Does Ellie tell me how to dose?

Never. Ellie records the regimen you and your prescriber chose and never suggests a dose or interval. It also builds a one-page summary you can give your doctor, so medication decisions happen where they belong.

Is this medical advice?

No. Ellie is an educational companion built on published research with sources cited in the app. Every medication decision belongs with you and your prescriber.

Is the app available now?

Yes. Ellie is live on the App Store for iPhone, free to download, with a subscription unlocking the full plan. An Android version will follow.